MAHWAH, N.J., Feb 23, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its ...

Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, has initiated a voluntary recall affecting the A3/A5 Anesthesia Delivery ...

The US Food and Drug Administration (FDA) is notifying healthcare professionals of a nationwide class I recall of A3 and A5 Anesthesia Delivery System units, some of which may have a gasket leak that ...

"The demand for more diversified and higher- quality anaesthesia practices are ever-growing. In response to this need, Mindray has developed the A7 and A5 anaesthesia systems, providing an integrated ...

The FDA issued a Class 1 recall of the Mindray A3 and A5 Anesthesia Delivery System, according to the American Society of Anesthesiologists. Some of the devices may have a gasket leak which would ...

Mindray Medical ($MR), China's largest medical device company, has launched a voluntary recall of its A3/A5 Anesthesia Delivery System, warning that the devices can ...

Mindray Medical International Limited has announced FDA approval of its A5 Anesthesia System, an anesthesia delivery platform, according to a company news release. The A5’s user interface is designed ...

has initiated a voluntary recall affecting the A3/A5 Anesthesia Delivery System. Mindray has initiated this recall due to the possibility of a system leak resulting from improper seating of the CO2 ...

Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under the A Series Anaesthesia. These enhancements ...